|
MedChemExpress
atp ![]() Atp, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/kif18a/KIF18A-IN-1/pmc11697083-469-17-25 Average 93 stars, based on 1 article reviews
atp - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Proteintech
kif18a antibody ![]() Kif18a Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/kif18a/KIF18A+Antibody/pmc11026273-60-4-7 Average 93 stars, based on 1 article reviews
kif18a antibody - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Fortis Life Sciences
anti kif18a Anti Kif18a, supplied by Fortis Life Sciences, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/kif18a/KIF18A+Antibody/pmc08129796-187-35-36 Average 93 stars, based on 1 article reviews
anti kif18a - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
OriGene
myc flag Myc Flag, supplied by OriGene, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/kif18a/KIF18A+(NM_031217)+Human+Tagged+ORF+Clone/ppr0876987-26-0-6 Average 92 stars, based on 1 article reviews
myc flag - by Bioz Stars,
2026-11
92/100 stars
|
Buy from Supplier |
|
MedChemExpress
vls 1272 ![]() Vls 1272, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/kif18a/VLS-1272/pm39747049-534-17-30 Average 93 stars, based on 1 article reviews
vls 1272 - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Novus Biologicals
kif18a ![]() Kif18a, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/kif18a/KIF18A+Antibody/pmc11784366-193-59-60 Average 93 stars, based on 1 article reviews
kif18a - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
mouse monoclonal anti kif18a ![]() Mouse Monoclonal Anti Kif18a, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/kif18a/KIF18A+Antibody/pmc06234775-125-0-12 Average 92 stars, based on 1 article reviews
mouse monoclonal anti kif18a - by Bioz Stars,
2026-11
92/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
kif18a sequences ![]() Kif18a Sequences, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/kif18a/KIF18A+siRNA/pm32094263-140-12-14 Average 92 stars, based on 1 article reviews
kif18a sequences - by Bioz Stars,
2026-11
92/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
kif18a ![]() Kif18a, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/kif18a/KIF18A+Lentiviral+Activation+Particles/pmc06642134-358-34-46 Average 90 stars, based on 1 article reviews
kif18a - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Thermo Fisher
gene exp kif18a hs01015428 m1 ![]() Gene Exp Kif18a Hs01015428 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/kif18a/Gene+Exp%2E+KIF18A%2C+Hs01015428_m1/pmc07900194-264-2-11 Average 90 stars, based on 1 article reviews
gene exp kif18a hs01015428 m1 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
smartvector inducible lentiviral shrna horizon ![]() Smartvector Inducible Lentiviral Shrna Horizon, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/kif18a/KIF18A+shRNA+Plasmid/pmc07889737-153-5-17 Average 92 stars, based on 1 article reviews
smartvector inducible lentiviral shrna horizon - by Bioz Stars,
2026-11
92/100 stars
|
Buy from Supplier |
|
Janssen
mitotic kinesin kif18a ![]() Mitotic Kinesin Kif18a, supplied by Janssen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/kif18a/kif18a+protein/pm38661008-255-24-19 Average 90 stars, based on 1 article reviews
mitotic kinesin kif18a - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Nature Communications
Article Title: Targeting chromosomally unstable tumors with a selective KIF18A inhibitor
doi: 10.1038/s41467-024-55300-z
Figure Lengend Snippet: a Structure of VLS-1272. b Potency of VLS-1272 in a KIF18A (1-374) biochemical ADP-Glo assay to measure ATPase activity with varied concentrations of ATP. Data presented as mean values from n = 2 biological replicates. c Inhibition of KIF18A (1-374) by VLS-1272 as measured by ADP-Glo assay in the absence or presence of 0.1 mg/ml microtubules. Data presented as individual values from n = 2 biological replicates. d Representative still images from microtubule gliding filament assays with purified KIF18A 1-480-GFP linked to the glass surface in absence (control) or presence of VLS-1272. Arrows indicate the ends of microtubules that move directionally (control) or remain stationary (VLS-1272). e Plot of microtubule velocities measured in gliding filament assays in the presence or absence of VLS-1272. n = 249 (control) and 177 (VLS-1272) microtubules from 3 independent experiments. Data were compared using an unpaired, two-tailed t -test. **** p < 1.0 x 10 -15 . Data points represent individual microtubule velocities, bars indicate mean and standard deviation. f Potency of VLS-1272 at various timepoints from a global progress curve analysis (GPCA). Data presented as mean values -/+ SD from n = 11 biological replicates. g Inhibition of HCC15 cell proliferation after 4-day treatment with VLS-1272 (black) versus 1 day of VLS-1272 treatment followed by a washout and replacement in media without inhibitor for an additional 3 days (pink). Data presented as individual values from n = 2 biological replicates. h Comparison of the K I calculated by GPCA vs. the EC50 from a 2.5-day CellTiter-Glo proliferation assay in JIMT-1 cells from n = 40 compounds. Each dot represents one compound. Compounds with poor permeability are denoted by “x”. Source data are provided in the Source Data file.
Article Snippet: For side-by-side comparison of VLS-1272 and AM-1882, reactions were performed with 1.25 nM KIF18A and 50 uM
Techniques: Glo Assay, Activity Assay, Inhibition, Purification, Control, Two Tailed Test, Standard Deviation, Comparison, Proliferation Assay, Permeability
Journal: Nature Communications
Article Title: Targeting chromosomally unstable tumors with a selective KIF18A inhibitor
doi: 10.1038/s41467-024-55300-z
Figure Lengend Snippet: Selectivity summary for VLS-1272 against a panel of human and mouse kinesins
Article Snippet: For side-by-side comparison of VLS-1272 and AM-1882, reactions were performed with 1.25 nM KIF18A and 50 uM
Techniques:
Journal: Digestive Diseases and Sciences
Article Title: Kinesin Family Member-18A (KIF18A) Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma
doi: 10.1007/s10620-024-08321-z
Figure Lengend Snippet: The association between KIF18A expression and clinicopathological feature in TGCA database. A – D The KIF18A mRNA expression level in primary HCC tissues ( n = 371) compared with normal tissues ( n = 50) ( B ), and the KIF18A mRNA expression level between nodal invasion ( B ), and between tumor grade ( C ) and clinical stage ( D ). E and F Kaplan–Meler survival analysis of disease-free survival and overall survival associated with KIF18A expression in HCC patients. G The KIF18A expression level in pan-cancer tissues from the TGGA database. (*** P < 0.001)
Article Snippet: The primary antibodies included
Techniques: Expressing
Journal: Digestive Diseases and Sciences
Article Title: Kinesin Family Member-18A (KIF18A) Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma
doi: 10.1007/s10620-024-08321-z
Figure Lengend Snippet: The expression of KIF18A in HCC cancer tissues. A and B Western blotting assay detects the KIF18A protein expression levels in HCC tissues and corresponding normal liver tissues ( n = 20 pairs) ( A ) and presents the gray value analysis ( B ). C Quantitative real-time PCR detects the KIF18A mRNA expression levels. D Immunohistochemical staining assays analyze the KIF18A expression in HCC tissues and corresponding normal liver tissues ( n = 10 pairs). The magnification of the pictures from top to bottom is 200 times and 400 times. E The immunostaining tissues were scored by IRS. F Multivariant analysis of hazard ratios (HR) of KIF18A expression levels including tumor size, TNM stage, microvascular invasion, and metastasis. (*** P < 0.001)
Article Snippet: The primary antibodies included
Techniques: Expressing, Western Blot, Real-time Polymerase Chain Reaction, Immunohistochemical staining, Staining, Immunostaining
Journal: Digestive Diseases and Sciences
Article Title: Kinesin Family Member-18A (KIF18A) Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma
doi: 10.1007/s10620-024-08321-z
Figure Lengend Snippet: Effect of KIF18A knockdown or overexpression on the proliferation of HCC cells. A and B Cell proliferation was analyzed by CCK-8 on KIF18A-silenced MHCC97-H and HLE. C and D Cell proliferation was analyzed by CCK-8 on KIF18A overexpression Huh-7 and PLC/PRF/5 cells. E Cell cycle distribution evaluated by using flow cytometry in KIF18A knockdown HCC cells. F Cell cycle distribution evaluated by using flow cytometry in KIF18A overexpression HCC cells. G and H The effect of KIF18A knockdown on tumor growth, tumor size, and tumor weight was evaluated by subcutaneous xenograft mouse model. I Reactome enrichment analysis enriched the differentially expressed genes after performing RNA-sequencing in KIF18A knockdown cells. J The effect of KIF18A knockdown or overexpression on CDK1, CyclinB1, and MAD2 proteins expression levels was tested by Western blotting assay. (** P < 0.01, *** P < 0.001)
Article Snippet: The primary antibodies included
Techniques: Knockdown, Over Expression, CCK-8 Assay, Flow Cytometry, RNA Sequencing, Expressing, Western Blot
Journal: Digestive Diseases and Sciences
Article Title: Kinesin Family Member-18A (KIF18A) Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma
doi: 10.1007/s10620-024-08321-z
Figure Lengend Snippet: Effect of KIF18A knockdown or overexpression on the migration and invasion of HCC cells. A and B The effect of KIF18A knockdown on cell migration was analyzed by wound healing assay in MHCC97-H and HLE cells. C and D The effect of KIF18A overexpression on cell migration was analyzed by wound healing assay in Huh-7 and PLC/PRF/5 cells. E and F The KIF18A knockdown on cell migration and invasion were analyzed by transwell assay in MHCC97-H and HLE cells. G and H The KIF18A overexpression on cell migration and invasion were analyzed by transwell assay in Huh-7 and PLC/PRF/5 cells. (I-J) Orthotopic xenograft mouse model was used to analyze the effect of KIF18A Knockdown on tumor growth and lung metastasis. (** P < 0.01, *** P < 0.001)
Article Snippet: The primary antibodies included
Techniques: Knockdown, Over Expression, Migration, Wound Healing Assay, Transwell Assay
Journal: Digestive Diseases and Sciences
Article Title: Kinesin Family Member-18A (KIF18A) Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma
doi: 10.1007/s10620-024-08321-z
Figure Lengend Snippet: The influence of KIF18A on TGF-β signaling pathway. A KEGG pathway enrichment analysis of the differentially expressed genes generated by RNA-seq showed that the TGF-β signaling pathway was significantly enriched, demonstrating the most statistically significant outcomes. B Western blotting assay was used to evaluate the effect of KIF18A knockdown or overexpression on p-SMA2/3, SMA2/3, E-cadherin, and N-cadherin proteins’ expression level in HCC cells. C Representative morphological images of KIF18A knockdown MHCC97-H cells and KIF18A-overexpresing Huh-7 cells. D and E Quantitative real-time PCR was used to analyze the effect of KIF18A knockdown or overexpression on EMT-associated genes’ expression level. F The possible signal pathway of KIF18A high expression affecting cell proliferation and cell metastasis in HCC cells. (* P < 0.05, ** P < 0.01, *** P < 0.001)
Article Snippet: The primary antibodies included
Techniques: Generated, RNA Sequencing, Western Blot, Knockdown, Over Expression, Expressing, Real-time Polymerase Chain Reaction
Journal: The Journal of Cell Biology
Article Title: Chromosome oscillation promotes Aurora A–dependent Hec1 phosphorylation and mitotic fidelity
doi: 10.1083/jcb.202006116
Figure Lengend Snippet: Video of chromosome oscillation in an RPE-1 cell treated with taxol, a HeLa cell depleted of Kif18A, a HeLa cell treated with BTB-1, and a HeLa cell treated with UMK57. Images were taken every 2 s, and video speed is 20 frames per second (sec).
Article Snippet: Polyclonal rabbit antibodies were used as follows: anti–phospho-Hec1 Ser 55 (GeneTex; GTX70017) IF 1:1,000; anti-Pericentrin (Abcam; ab4448) IF 1:1,000; anti–Aurora A (Abcam; ab12875) WB 1:2,000, IF 1:1,000; anti-INCENP (P240; Cell Signaling Technology; #2807) WB 1:500; anti-Kif18A (Bethyl Laboratories; A301-080A) WB 1:2,000; anti-GFP (Life Technologies; A11122) IF 1:2,000; and anti–α-tubulin (Abcam; ab18251) IF 1:1,000.
Techniques:
Journal: Nature communications
Article Title: Targeting chromosomally unstable tumors with a selective KIF18A inhibitor.
doi: 10.1038/s41467-024-55300-z
Figure Lengend Snippet: Fig. 3 | Development of KIF18A inhibitors. a Structure of VLS-1272. b Potency of VLS-1272 in a KIF18A (1-374) biochemical ADP-Glo assay to measure ATPase activity with varied concentrations of ATP. Data presented as mean values from n = 2 biological replicates. c Inhibition of KIF18A (1-374) by VLS-1272 as measured by ADP-Glo assay in the absence or presence of 0.1 mg/ml microtubules. Data presented as individual values from n = 2 biological replicates. d Representative still images from microtubule gliding filament assays with purified KIF18A 1-480- GFP linked to the glass surface in absence (control) or presence of VLS-1272. Arrows indicate the ends of microtubules that move directionally (control) or remain stationary (VLS-1272). e Plot of microtubule velocities measured in gliding filament assays in the presence or absence of VLS-1272. n = 249 (control) and 177 (VLS-1272) microtubules from 3 independent experiments. Data were compared
Article Snippet: For single dose PK studies, 6–8-week-old male CD-1 mice (Jihui Laboratory Animal Co. Ltd.) were administered 1mg/kg
Techniques: Glo Assay, Activity Assay, Inhibition, Control
Journal: Journal of Virology
Article Title: HPV16 entry requires dynein for minus-end transport and utilizes kinesin Kif11 for plus-end transport along microtubules during mitosis
doi: 10.1128/jvi.00937-24
Figure Lengend Snippet: Kif11 inhibitor reduces transport of EdU-labeled PSVs to mitotic chromosomes. HaCaT cells were infected with WT EdU-labeled PsVs for 24 h and then treated with 1.5 µM Kif11 inhibitor (Eg5 inh+) or left untreated (Ctrl) for 10 min prior to the cells being stained and subjected to the Click-iT reaction as previously described in Materials and Methods. ( A ) AF555 dye was used to stain EdU-labeled pseudogenomes (red), mouse anti-α-tubulin antibody was used to stain for α-tubulin (white), and rabbit anti-Kif11 antibody was used to stain for Kif11 (green). Left-hand panel of Ctrl row of ( A ) is of an infected HaCaT cell in prophase, and the right-hand panel of Ctrl row of ( A ) is of an infected HaCaT cell in metaphase. Since Eg5 inh+ treatment locks cells into a monoastral phenotype , both the left-hand and right-panels of the Eg5 inh+ row of ( A ) are of pre-monoastral cells. Two smaller close-up images, rotated at a 45° angle on the x-, y-, and z-axes, are included on the right-side of the main image(s) to better show close association, or lack thereof in Eg5 inh+, between EdU-labeled HPV genome and Kif11. ( B ) AF555 dye was again used to stain EdU-labeled pseudogenomes in cells undergoing mitosis at prophase or metaphase (red), and mitotic chromosomes were visualized using Hoechst (blue). Images represent single medial slices. ( C ) Quantification of EdU-labeled HPV16 PsV in whole cells +/−Eg5 inh+ treatment; at least 20 cells per group, control and Eg5 inh+ were counted, with 69 total cells counted (group numbers of 21, 26, and 22). Localization of EdU puncta (red) was analyzed with IMARIS using spots/surface analysis. The number of pseudogenomes in whole cells was established based on alpha tubulin and EdU-labeled HPV genome signals; determining genome and the localization on mitotic chromosomes was based on Hoechst staining. Lines in graph represent mean with SEM, and statistical significance was assessed by Student t -test, N = 3, ns: P > 0.05. ( D ) Quantification of EdU-labeled HPV16 PsV (red) co-localized with mitotic chromatin (blue) upon Kif11 inhibitor treatment using IMARIS. At least 20 cells per group, control and Eg5 inh+ were counted, with 66 total cells counted (group numbers of 21, 25, and 20). Lines in graph represent mean with SEM, and statistical significance was assessed by Mann Whitney test, N = 3, ***: P < 0.001. ( E ) Uninfected HaCaT cells were treated with 1.5 µM Eg5 inhibitor for 10 min and then stained for Kif11 and Kif18a as previously described in Materials and Methods, except cells were also subjected to the Click-iT reaction, but without the AF555 dye to stain for kinesins under denaturing conditions. Either Kif11 or Kif18A was stained using anti-rabbit Kif11 or anti-rabbit Kif18A antibodies, respectively (red). Mouse anti-α-tubulin antibody was used to stain α-tubulin (green), and cell nuclei were visualized using Hoechst (blue). Images represent single medial slices.
Article Snippet: Primary antibodies used for the immunofluorescence studies were as follows: mouse monoclonal antibody (mAb) anti-α-tubulin (Cell Signaling; #3873S), mouse mAb AlexaFluor (AF) 488-conjugated anti-α-tubulin (Cell Signaling; #8058), mouse mAb anti-γ-tubulin for the detection of the MTOC (Sigma-Aldrich; #T6557), rabbit mAb anti-dynein intermediate chain 1 (Abcam; #ab171964); all rabbit mAbs for detection of kinesins such as Kif11 (Cell Signaling; #14404S),
Techniques: Labeling, Infection, Staining, Control, MANN-WHITNEY
Journal: Journal of Virology
Article Title: HPV16 entry requires dynein for minus-end transport and utilizes kinesin Kif11 for plus-end transport along microtubules during mitosis
doi: 10.1128/jvi.00937-24
Figure Lengend Snippet: Kinesin motor proteins are in proximity to HPV16 L2 protein during infection. ( A ) HEK293TT cells were transfected with plasmids encoding HA-tagged HPV16 L2 and FLAG-tagged Kif11 to perform a co-immunoprecipitation (CoIP) assay using anti-HA beads; pCMV6 plasmid was used for the CoIP empty vector controls. CoIPs were performed with (right-hand panel) or without (left-hand panel) transfected cells treated with Kif11 inhibitor (1.5 µM; “Eg5i”) 1 or 2 h prior to cell harvesting for CoIP. Tagged HPV16 L2 and Kif11 proteins were probed for via Western blot using anti-HA and anti-FLAG antibodies, respectively, in both whole-cell lysates (“Lysate”) and anti-HA bead elutions (“elute”); anti α-tubulin Western blots were used as a loading control for the lysates. The enclosed immunoblots are representative of at least two independent experiments ( N = 2). ( B ) Mock-infected (“Mock”) and PsV16-infected (“Infected”) HaCaT cells were processed using the proximity ligation assay (PLA) protocol 21 hpi. PLAs were performed using an antibody cocktail to target the HPV16 L2 protein and an individually selected kinesin, either Kif11, Kif18a, or Kif25. The HPV16L2 antibodies used are the same throughout all PLAs, while the specific kinesin antibody used for the indicated PLA is identified in the left-hand margin of the images. PLA puncta were visualized in the representative images as red dots. Confocal images were acquired as z-stacks and processed as described in Materials and Methods. The white arrows highlight mitotic cells in their representative images for the PLAs. ( C ) The average PLA puncta numbers per interphase cells were counted for at least 200 cells per group in one experiment and are presented as median with 95% CI in the corresponding graphs for the PLAs in the middle panels adjacent to their representative images. The average PLA puncta numbers per mock-infected versus PSV-infected interphase cell were (median) 0.43 vs 6.8 (Kif11), 0.83 vs 5.8 (Kif18A), and 1.8 vs 4.1 (Kif25). Differences between mock and infected cells were analyzed using Mann–Whitney test, ( N = 3); **** P < 0.0001. ( D ) The average PLA puncta numbers were counted per at least 20 mitotic cells for each condition and are presented as median with 95% CI. Mock-infected vs PSV-infected PLA puncta numbers per mitotic cell were (median) 0.0 vs 6.0 (Kif11), 0.0 vs 5.0 (Kif18A), and 1.0 vs 5.5 (Kif25). Differences between mock and infected cells were analyzed using Mann–Whitney test, **** P < 0.0001.
Article Snippet: Primary antibodies used for the immunofluorescence studies were as follows: mouse monoclonal antibody (mAb) anti-α-tubulin (Cell Signaling; #3873S), mouse mAb AlexaFluor (AF) 488-conjugated anti-α-tubulin (Cell Signaling; #8058), mouse mAb anti-γ-tubulin for the detection of the MTOC (Sigma-Aldrich; #T6557), rabbit mAb anti-dynein intermediate chain 1 (Abcam; #ab171964); all rabbit mAbs for detection of kinesins such as Kif11 (Cell Signaling; #14404S),
Techniques: Infection, Transfection, Immunoprecipitation, Co-Immunoprecipitation Assay, Plasmid Preparation, Cell Harvesting, Western Blot, Control, Proximity Ligation Assay, MANN-WHITNEY
Journal: Journal of cell science
Article Title: Kinesin KIF18A is a novel PUM-regulated target promoting mitotic progression and survival of a human male germ cell line.
doi: 10.1242/jcs.240986
Figure Lengend Snippet: Fig. 2 The effect of PUM1 and PUM2 on the expression of KIF18A LUC-3’UTR construct
Article Snippet: TCam-2 cells were transfected with 40 nM siRNA mixture of 3 different
Techniques: Expressing, Construct
Journal: Journal of cell science
Article Title: Kinesin KIF18A is a novel PUM-regulated target promoting mitotic progression and survival of a human male germ cell line.
doi: 10.1242/jcs.240986
Figure Lengend Snippet: Fig. 3 Effect of KIF18A, PUM1 and PUM2 knockdown on cells proliferation. A - The MTS
Article Snippet: TCam-2 cells were transfected with 40 nM siRNA mixture of 3 different
Techniques: Knockdown
Journal: Journal of cell science
Article Title: Kinesin KIF18A is a novel PUM-regulated target promoting mitotic progression and survival of a human male germ cell line.
doi: 10.1242/jcs.240986
Figure Lengend Snippet: Fig. 4 The effect of KIF18A siRNA silencing on apoptosis, as measured using imaging flow
Article Snippet: TCam-2 cells were transfected with 40 nM siRNA mixture of 3 different
Techniques: Imaging
Journal: Journal of cell science
Article Title: Kinesin KIF18A is a novel PUM-regulated target promoting mitotic progression and survival of a human male germ cell line.
doi: 10.1242/jcs.240986
Figure Lengend Snippet: Fig. 5 The effect of KIF18A siRNA silencing on the cell cycle, as measured by flow
Article Snippet: TCam-2 cells were transfected with 40 nM siRNA mixture of 3 different
Techniques:
Journal: Nature Communications
Article Title: Chromosomally unstable tumor cells specifically require KIF18A for proliferation
doi: 10.1038/s41467-021-21447-2
Figure Lengend Snippet: a Fold change in cell density (cells/mm 2 ) after 96 h in the indicated cell lines following knockdown (KD) of kinesin proteins. Data are normalized to cells treated with control siRNA. Raw cell counts for proliferation assays are available in Source Data. n (wells of cells/independent experiments) = 24/3 (MCF10A, MDA-MB-468, and HCC1806), 64/5 (MDA-MB-231 control and KIF18A KD), 36/3 (MDA-MB-231 KIF18B, KIF4A, KIF22, and MCAK KD). b Representative images of MDA-MB-231 (from five experiments) and MCF10A cells (from three experiments) treated with either control or KIF18A siRNA. Scale bars are 100 microns. c Normalized fold change in cell density (cells/mm 2 ) of MSI and CIN colorectal cancer cell lines after 96 h or until cells in the control populations reached confluence. n (wells of cells/independent experiments) = 88/6 (HCT116); 104/5 (LoVo control KD) and 128/5 (LoVo KIF18A KD); 92/5 (SW480); 44/3 (HT29 control KD) and 48/3 (HT29 KIF18A KD); and 32/3 (LS1034). d Normalized fold change in cell density (cells/mm 2 ) of HeLa Kyoto cells after 96 h or until cells in the control populations reached confluence. n = 40 wells of cells from two independent experiments. Data were analyzed using a one-way ANOVA with post hoc Tukey’s test to compare the control to each of the knockdown conditions ( a ) or with an unpaired, two-tailed t test ( c , d ). All graphs show mean ± SD and individual data points. P values <0.05 from the indicated statistical tests are displayed on plots.
Article Snippet: Human GAPDH (
Techniques: Knockdown, Control, Two Tailed Test
Journal: Nature Communications
Article Title: Chromosomally unstable tumor cells specifically require KIF18A for proliferation
doi: 10.1038/s41467-021-21447-2
Figure Lengend Snippet: a , b Representative images from five and three independent experiments of HT29 ( a ) or HCT116 cells, respectively, ( b ) treated with control or KIF18A siRNAs. DNA (DAPI, blue), microtubules (α-tubulin, white), and centromeres (ACA, red) are labeled. Scale bars are 10 microns. c Percentage of mitotic cells (mitotic index) observed in fixed populations of control or KIF18A siRNA-treated CRC cells. n = three independent biological samples per condition for LS1034, SW480, HCT116, and LoVo; n = 5 for HT29. Data were analyzed via unpaired, two-tailed t test. d Time between nuclear envelope breakdown (NEB) and anaphase onset (AO) in control or KIF18A siRNA-treated cells. Data from three independent experiments are shown for each cell line. n (control KD/KIF18A KD cells) = 185/ 83 (HT29), 182/135 (MDA-MB-231), 203/196 (LS1034), 303/236 (SW480), 332/344 (HCT116), and 338/353 (MCF10A). Data were analyzed via unpaired, two-tailed t test. e Percentage of control or KIF18A siRNA-treated cells that entered mitosis at least 200 min before the end of the movie but did not divide. Data are from the same three experiments as d and were analyzed by a two-sided Chi-square test. n (control KD/KIF18A KD cells) = 191/153 (HT29), 189/195 (MDA-MB-231), 203/202 (LS1034), 310/249 (SW480), 335/351 (HCT116), and 338/367 (MCF10A). f Frames from DIC live-cell imaging of HT29 and MCF10A cells treated with control or KIF18A (KD) siRNAs, showing the progression from NEB to AO. Scale bars are 5 microns, representative of three independent experiments. All graphs show mean ± SD and individual data points. P values <0.05 are displayed.
Article Snippet: Human GAPDH (
Techniques: Control, Labeling, Two Tailed Test, Live Cell Imaging
Journal: Nature Communications
Article Title: Chromosomally unstable tumor cells specifically require KIF18A for proliferation
doi: 10.1038/s41467-021-21447-2
Figure Lengend Snippet: a Representative images from five independent experiments of MDA-MB-231 cells treated with either control (top) or KIF18A (bottom) siRNAs. Pericentriolar material (γ-tubulin, red) is numbered to show poles with and without centrioles (centrin-1, green). Microtubules (α-tubulin) are labeled in white. b Percent of mitotic cells from each indicated cell line with multipolar spindles following treatment with either control or KIF18A siRNA. n = 9 (control KD) and 5 (KIF18A KD) independent experimental replicates for MDA-MB-231. n = 3 (HT29, HCC1806, SW480), 4 (HeLa), and 5 (MCF10A) independent experimental replicates. Data were analyzed via unpaired, two-tailed t test. c Plot of multipolar spindle percentage as a function of fold change (FC) in cell number for the indicated cell lines following KIF18A KD. R-squared value is 0.79 using a linear regression model. d Representative images from three independent experiments of an MDA-MB-231 cell with a third pole (γ-tubulin, magenta) lacking centrin-1 (green). e Percent of multipolar MDA-MB-231 cells in mitosis with fragmented pericentriolar material (PCM), as indicated by the presence of γ-tubulin puncta lacking centrin-1 puncta. n = 18 (control KD) and 58 (KIF18A KD) multipolar cells from three independent experiments. Data were analyzed via a two-sided Chi-square test. f Intercentriolar distance measurements (in microns) for MDA-MB-231 cells in each indicated category. n = 81 (control KD bipolar), 38 (control KD multipolar), 94 (KIF18A KD bipolar), and 91 (KIF18A KD multipolar) centriole pairs from three independent experiments. Data were analyzed via one-way ANOVA with post hoc Tukey’s test for multiple comparisons. g Representative still frames from three independent experiments of a live MDA-MB-231 KIF18A KD cell labeled with siR-tubulin. Arrows indicate pole splitting and separation. h , i Percent of live, siR-tubulin-labeled MDA-MB-231 cells that ( h ) enter mitosis with more than two spindle poles or ( i ) split and separate spindle poles during mitosis. n = 126 (control KD) and 172 (KIF18A KD) cells from three independent experiments. Data were analyzed by a two-sided Chi-square test. All graphs show mean ± SD and individual data points. P values <0.05 are displayed. All scale bars are 10 microns.
Article Snippet: Human GAPDH (
Techniques: Control, Labeling, Two Tailed Test
Journal: Nature Communications
Article Title: Chromosomally unstable tumor cells specifically require KIF18A for proliferation
doi: 10.1038/s41467-021-21447-2
Figure Lengend Snippet: a , b Percent of fixed MDA-MB-231 cells ( a ) in mitosis or ( b ) with multipolar spindles after the indicated siRNA knockdown (KD). n = 3 independent biological samples for all conditions in a , and n = 3 (MAD2 KD) or 4 (control, KIF18A, and KIF18A & MAD2 KD) in b . Data were analyzed via one-way ANOVA with post hoc Tukey’s test for multiple comparisons ( a ) or two-sided Chi-square test ( b ). P values <0.05 are displayed. c , d Percent of live, siR-tubulin-labeled MDA-MD-231 cells that ( c ) split poles during mitosis or ( d ) entered mitosis with more than two spindle poles. n (number of cells/number of independent experiments) = 126/3 (control), 172/3 (KIF18A), 127/2 (MAD2), and 117/2 (KIF18A and MAD2). All bars represent mean, and error bars represent SD. Individual data points are shown. e Stacked histogram showing relative frequencies of the duration of time between NEB and pole splitting for siR-tubulin-labeled MDA-MB-231 cells following KIF18A KD or KIF18A and MAD2 KD. f Western blots of MAD2, KIF18A, and GAPDH following treatment with either a double dose of control siRNA or a combination of KIF18A and MAD2 siRNA.
Article Snippet: Human GAPDH (
Techniques: Knockdown, Control, Labeling, Western Blot
Journal: Nature Communications
Article Title: Chromosomally unstable tumor cells specifically require KIF18A for proliferation
doi: 10.1038/s41467-021-21447-2
Figure Lengend Snippet: a Percent of MDA-MB-231 cells with multipolar spindles in control or KIF18A KD cells treated with either DMSO, 20 nM Paclitaxel (Pac), or 5 μM Nocodazole (Noc) for 3 h. n = 151 (control KD + DMSO), 263, (KIF18A KD + DMSO), 189 (control KD + pac), 218 (KIF18A KD + pac), 155 (control KD + noc), and 158 (KIF18A KD + noc) cells from three independent experiments. Data were analyzed via a two-sided Chi-square test. b Percentage of mitotic cells with multipolar spindles in fixed MDA-MB-231 or MCF10A after the indicated treatments. n = 9 (control KD), 5 (KIF18A KD), 3 (DMSO), and 5 (paclitaxel) independent experimental replicates for MDA-MB-231 cells. n = 7 (control KD), 5 (KIF18A KD), 3 (DMSO), and 6 (paclitaxel) independent experimental replicates for MCF10A cells. Data were analyzed via a two-sided Chi-square test. c Percentage of fixed MDA-MB-231 and MCF10A cells in mitosis following the indicated treatments. n = 4 independent biological samples for all conditions. Data were analyzed via one-way ANOVA with post hoc Tukey’s test for multiple comparisons. All graphs show mean ± SD with individual data points indicated. P values <0.05 from the indicated statistical tests are displayed.
Article Snippet: Human GAPDH (
Techniques: Control
Journal: Nature Communications
Article Title: Chromosomally unstable tumor cells specifically require KIF18A for proliferation
doi: 10.1038/s41467-021-21447-2
Figure Lengend Snippet: a Percent of monopolar MDA-MB-231 cells with three or more γ-tubulin puncta in control or KIF18A KD cells treated with both monastrol (20 μM) and either DMSO or 20 nM Paclitaxel (Pac). n (number of monopolar mitotic cells/number of independent experiments) = 112/4 (control KD + DMSO), 102/4 (KIF18A KD + DMSO), 132/3 (control KD + Pac), and 149/3 (KIF18A KD + Pac). The plot shows mean ± SD with individual data points indicated. Data were analyzed via a two-sided Chi-square test, and P values <0.05 are displayed. b Representative images (from three independent experiments) of MDA-MB-231 cells treated with 20 μM monastrol and either DMSO or 20 nM Paclitaxel. DNA (DAPI, blue), microtubules (α-tubulin, red), and centrosomes (γ-tubulin, green) are labeled. Scale bar is 5 microns.
Article Snippet: Human GAPDH (
Techniques: Control, Labeling
Journal: Nature Communications
Article Title: Chromosomally unstable tumor cells specifically require KIF18A for proliferation
doi: 10.1038/s41467-021-21447-2
Figure Lengend Snippet: a Representative images (from three independent experiments) of MDA-MB-231 cell density 96 h after the start of high-contrast bright-field imaging. Cells were treated with either control or KIF18A siRNAs in combination with DMSO or 500 nM UMK57. Scale bar is 100 microns. b Fold change in cell density after 96 h in MDA-MB-231 cells treated with the specified siRNAs and either 500 nM UMK57 or DMSO. n = 76 (control KD + DMSO), 52 (control KD + UMK57), 76 (KIF18A KD + DMSO), and 68 (KIF18A KD + UMK57) wells of cells from three independent experiments. Data were analyzed via one-way ANOVA with post hoc Tukey’s test for multiple comparisons. c , d Percent of total mitotic cells ( c ) and mitotic cells with multipolar spindles ( d ) in fixed populations after the indicated treatments. n = 3 independent experimental replicates per condition. Data were analyzed via one-way ANOVA with post hoc Tukey’s test for multiple comparisons. e , f Percent of live, siR-tubulin-labeled MDA-MB-231 cells that ( e ) split poles or ( f ) entered mitosis with more than two spindle poles after the indicated treatments. n = 126 (control KD + DMSO), 158 (control KD + UMK57), 172 (KIF18A KD + DMSO), and 152 (KIF18A KD + UMK57) mitotic cells from three independent experiments. Data were analyzed via a two-sided Chi-square test. All graphs show mean ± SD and individual data points. P values <0.05 are displayed.
Article Snippet: Human GAPDH (
Techniques: Imaging, Control, Labeling
Journal: Nature Communications
Article Title: Chromosomally unstable tumor cells specifically require KIF18A for proliferation
doi: 10.1038/s41467-021-21447-2
Figure Lengend Snippet: Schematic summarizing the differential responses of CIN and near-diploid cells to KIF18A knockdown (KD). Increased microtubule polymerization rates in CIN cells may sensitize them to further deregulation of microtubule dynamics caused by loss of KIF18A function, leading to force imbalances that disrupt the integrity of the spindle. See “Discussion” for additional detail.
Article Snippet: Human GAPDH (
Techniques: Knockdown
Journal: Nature
Article Title: Whole genome doubling confers unique genetic vulnerabilities on tumor cells
doi: 10.1038/s41586-020-03133-3
Figure Lengend Snippet: (a) Workflow used to identify gene essentiality in WGD + cancer cells from Project Achilles data (see ). (b) Top hits from PSL analysis (text color indicates genes associated with indicated pathways). (c) Gene expression fold changes in WGD + tumors relative to WGD – tumors plotted against combined FDR values across all tumor types with select PSL genes highlighted. (d) Population doublings after 8 days of AZ3146 treatment (n = 3 independent experiments; two-way ANOVA with interaction; graph shows mean +/− SEM; interaction p-values = 0.0085, 0.0020, 0.0156, respectively). (e) Relative viability of indicated cell lines 7 days after treatment with indicated siRNA (n = 3 independent experiments; graph shows mean +/− SEM). (f) Mean LC 50 for 5 WGD – and 5 WGD + breast cancer cell lines for indicated drug treatments (n = 3 independent experiments; nonlinear regression; graphs show mean LC 50 +/− 95% CI). * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001
Article Snippet: We infected cells with a
Techniques: Gene Expression
Journal: Nature
Article Title: Whole genome doubling confers unique genetic vulnerabilities on tumor cells
doi: 10.1038/s41586-020-03133-3
Figure Lengend Snippet: (a) Mitotic duration of indicated cells following indicated treatments (n = 200 cells; Student’s unpaired t-test – two-sided; graph shows mean +/− SEM; p-values = <0.0001, <0.0001, 0.0265, respectively). (b) The fraction of mitoses that generate micronuclei following indicated treatments (n = 200 cells; Student’s unpaired t-test – two-sided; p-values = <0.0001, <0.0001, <0.0001, <0.0001, 0.0002, <0.0001, respectively). (c) Relative viability of 2N and 4N HCT116 cells 7 days after treatment with indicated siRNA at indicated concentrations with Western blot showing protein knockdown 48 hours after treatment with siRNA (n = 3 independent experiments; graph shows mean +/− SEM at each dose; for gel source see ). (d) Relative viability of 2N and 4N MCF10A cells 7 days after treatment with indicated siRNA at 50 pM concentration (n =3 independent experiments; Student’s unpaired t-test – one-sided; graph shows mean +/− SEM; p-values = <0.0001, <0.0001). (e) Relative viability of 2N and 4N RPE cells 5 days after treatment with indicated siRNA at 50 pM concentration (n = 3 independent experiments; Student’s unpaired t-test – one-sided; graph shows mean +/− SEM; p-values = 0.090, 0.0007, respectively). (f) Representative Western blot showing knockdown of indicated proteins 48 hours after treatment with indicated siRNA (n = 3 independent experiments; for gel source see ). * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001
Article Snippet: We infected cells with a
Techniques: Western Blot, Knockdown, Concentration Assay
Journal: Nature
Article Title: Whole genome doubling confers unique genetic vulnerabilities on tumor cells
doi: 10.1038/s41586-020-03133-3
Figure Lengend Snippet: (a-b) Dose-response to indicated treatment after 7 days in indicated cell lines with accompanying LC 50 (n = 3 independent experiments; nonlinear regression with variable slope; graphs show mean relative viability +/− SEM at each dose and mean LC 50 +/− 95% CI). (c-e) Dose-response curves for 5 WGD – and 5 WGD + breast cancer cell lines 7 days after indicated drug treatment at the indicated concentrations (n = 3 independent experiments; nonlinear regression with variable slope; graph shows mean +/− SEM at each dose). (f) Representative Western blot showing knockdown of indicated proteins in breast cancer cell lines 48 hours after treatment with indicated siRNA (n = 3 independent experiments; for gel source see ). (g) Relative viability decrease in WGD + and WGD – breast cancer cell lines 7 days after treatment with indicated siRNA (Wilcoxon rank-sum test – two-sided; graph shows mean +/− SEM; p-values = <0.0001, 0.0027, respectively) * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001
Article Snippet: We infected cells with a
Techniques: Western Blot, Knockdown
Journal: Nature
Article Title: Whole genome doubling confers unique genetic vulnerabilities on tumor cells
doi: 10.1038/s41586-020-03133-3
Figure Lengend Snippet: (a) Dose-response to MG132 treatment after 7 days in indicated cell lines with accompanying LC 50 (n = 3 independent experiments; nonlinear regression with variable slope; graphs show mean relative viability +/− SEM at each dose and mean LC 50 +/− 95% CI). (b) Progression free survival and overall survival in patients with upper tertile tumor expression of KIF18A in the TCGA (Cox proportional-hazards regression; graph shows hazard ratios +/− 95% CI). (c) Representative Western blot showing KIF18A levels following transfection with the indicated siRNAs in the indicated cell lines (n = 3 independent experiments; for gel source see ). (d) Anaphase phenotypes following depletion of KIF18A (n = 20 cells per condition; stars indicate p-value for two-sided Fisher’s exact test comparing the fraction of anaphases with lagging chromosomes; p-values = <0.0001, 0.0033, 0.0187, respectively). (e) Representative confocal images showing phases of mitosis in indicated cell lines 48 hours after transfection with indicated siRNA (representative images from 2 independent experiments; scale bar 10 μm). (f) Representative still images from 2N and 4N MCF10A cells progressing through mitosis after transfection with the indicated siRNAs. H2B-GFP labeled chromosomes are shown in white. Arrows in enlarged images show oscillating chromosomes during metaphase and the generation of a micronucleus (hrs: min; scale bar 10 μm) * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001
Article Snippet: We infected cells with a
Techniques: Expressing, Western Blot, Transfection, Labeling
Journal: Nature
Article Title: Whole genome doubling confers unique genetic vulnerabilities on tumor cells
doi: 10.1038/s41586-020-03133-3
Figure Lengend Snippet: (a) Relative viability of indicated cell lines 8 days after transfection with the indicated siRNAs (n = 3 independent experiments; each condition normalized to respective control; Student’s unpaired t-test – two-sided; graph shows mean +/− SEM; p-values = 0.0019, 0.0109, 0.0017, respectively). (b) Mitotic duration and fate after treatment with indicated siRNA (n = 200 cells per condition; black stars indicate p-value for two-sided Student’s t-test comparing mean mitotic duration; blue stars indicate p-value for two-sided Fisher’s exact test comparing the fraction of mitoses that give rise to micronuclei; dotted line represents mean mitotic duration). (c) Measurement of spindle length (centrosome-to-centrosome) after transfection with indicated siRNA (n = 20 cells per condition; two-way ANOVA with interaction; graph shows mean +/− SEM; scale bar 10 μm; interaction p-values = 0.0001, 0.0011, 0.0032, respectively). (d) Image demonstrating measurement of chromosome oscillations immediately prior to anaphase by assessing the widest oscillating chromosomes in each poleward direction and the cross-sectional area of all the chromosomes (scale bar 10 μm). (e) Widest oscillating chromosome in each poleward direction immediately prior to anaphase (n = 20 cells per condition from 2 independent experiments; two-way ANOVA with interaction; interaction p-values = 0.0025, <0.0001, <0.0001, respectively). (f) Two-dimensional cross-sectional area of the entire body of chromosomes immediately prior to anaphase (n = 20 cells per condition; Student’s unpaired t-test – two-sided; graph shows mean +/− SEM; p-values = 0.0012, <0.0001, 0.0525, 0.0318, <0.0001, 0.0318, 0.0432, respectively). (g) Representative confocal images showing phases of mitosis in indicated cell lines 48 hours after transfection with indicated siRNA (scale bar 10 μm). * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001
Article Snippet: We infected cells with a
Techniques: Transfection, Control
Journal: Nature
Article Title: Whole genome doubling confers unique genetic vulnerabilities on tumor cells
doi: 10.1038/s41586-020-03133-3
Figure Lengend Snippet: (a) Representative image of a 4N MCF10A cell 4 days after transfection with siKIF18A and stained for cGAS. Graph shows the fraction of micronuclei in 2N and 4N MCF10A cells with indicated treatment that stained positive for cGAS (n = 200 micronuclei per condition; Fisher’s exact test – two-sided; scale bar 10 μm; p-values = <0.0001, 0.0069, respectively). (b-c) Representative confocal images of indicated cell lines 48 hours after transfection with indicated siRNA. Arrows highlight MAD1 positive kinetochores in misaligned chromosomes (scale bar 10 μm; representative images from 2 independent experiments). (d) Representative Western blot of indicated protein levels after treatment with indicated siRNA and accompanying graphs showing relative protein levels normalized to loading control (n = 3 independent experiments; Student’s unpaired t-test – one-sided; graph shows mean +/− SEM; p-values = 0.0337, 0.0030, 0.0674, 0.0421, 0.0067, 0.0227, respectively; for gel source see ). (e) Cell fates of indicated cell lines tracked for 3 days beginning 18 hours after transfection with indicated siRNA (n = 40 cells per condition; two-sided Fisher’s exact test comparing fraction of cells arresting/delaying in interphase relative to control group; p values = 0.0016, <0.0001, <0.0001, respectively). (f) Relative viability of indicated cell lines 4 days after transfection with the indicated siRNA (n = 3 independent experiments; Student’s unpaired t-test – two-sided; graph shows mean +/− SEM; p-values = 0.0132, 0.0310, 0.8808, 0.8615, respectively). * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001
Article Snippet: We infected cells with a
Techniques: Transfection, Staining, Western Blot, Control
Journal: Nature
Article Title: Whole genome doubling confers unique genetic vulnerabilities on tumor cells
doi: 10.1038/s41586-020-03133-3
Figure Lengend Snippet: (a) Western blot showing endogenous KIF18A levels in indicated cell lines with graph showing respective protein levels normalized to GAPDH loading control (representative blot from 3 independent experiments; for gel source see ). (b) Representative Western blot showing KIF18A levels 48 hours after transfection with indicated siRNA (n = 3 independent experiments; for gel source see ). (c) Relative viability decrease in WGD + and WGD – breast cancer cell lines 7 days after treatment with indicated siRNA (n = 3 independent experiments; Wilcoxon rank-sum test – two-sided; graph shows mean +/− SEM; p-value < 0.0001). (d) Relative viability 7 days after induction of Cas9 in cells with sgRNA targeting KIF18A with Western blot showing protein depletion 72 hours after induction (n = 3 independent experiments; graph shows mean +/− SEM; Student’s unpaired t-test – two-sided; p-values = 0.0007, < 0.0001, respectively; for gel source see ). (e) Relative viability 7 days after induction of shRNA targeting KIF18A with Western blot showing protein depletion 120 hours after induction (n = 3 independent experiments; graph shows mean +/− SEM; Student’s unpaired t-test – one-sided; p-value < 0.0001; for gel source see ). (f) Widest oscillating chromosome in each poleward direction immediately prior to anaphase (n = 20 cells per condition; Student’s unpaired t-test – two-sided; p-values = 0.0022, 0.1781, 0.1487, 0.0136, 0.0820, <0.0001, <0.0001, <0.0001, <0.0001, 0.4132, respectively). (g) Two-dimensional cross-sectional area of the entire body of chromosomes immediately prior to anaphase (n = 20 cells per condition; Student’s unpaired t-test – two-sided; p-values = 0.1178, 0.7545, 0.1440, 0.0034, 0.9989, 0.0005, 0.0033, 0.0012, 0.0110, 0.9089, respectively; graph shows mean +/− SEM). * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001
Article Snippet: We infected cells with a
Techniques: Western Blot, Control, Transfection, shRNA
Journal: Nature
Article Title: Whole genome doubling confers unique genetic vulnerabilities on tumor cells
doi: 10.1038/s41586-020-03133-3
Figure Lengend Snippet: (a) Relative viability of cell lines 8 days after transfection with the indicated siRNAs (n = 3 independent experiments; graph shows mean +/− SEM). (b) Mitotic duration and fate following transfection with indicated siRNA (n = 80 cells per condition across 2 independent experiments; dotted line represents mean mitotic duration; black stars indicate p-values for two-sided Student’s unpaired t-test comparing mean mitotic duration; blue stars indicate p-values for two-sided Fisher’s exact test comparing fraction of mitoses that give rise to micronuclei; red stars indicate p-values for two-sided Fisher’s exact test comparing fraction of cell that die in mitosis). (c) Depletion of KIF18A impairs WGD + cell viability through two distinct mechanisms: A) Widely oscillating chromosomes fail to properly attach to microtubules, thus activating the spindle assembly checkpoint and leading to prolonged mitosis and death. B) Larger spindles and wider oscillations increase the distance some chromosomes must traverse in anaphase leading to lagging chromosomes, micronuclei formation, and cellular arrest. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001
Article Snippet: We infected cells with a
Techniques: Transfection
Journal: Nature
Article Title: Whole genome doubling confers unique genetic vulnerabilities on tumor cells
doi: 10.1038/s41586-020-03133-3
Figure Lengend Snippet: (a) Measurement of spindle length (centrosome-to-centrosome) after transfection with indicated siRNA (n = 20 cells per condition; Student’s unpaired t-test – two-sided; graph shows mean +/− SEM). (b) Anaphase phenotypes following depletion of KIF18A (n = 20 cells per condition; stars indicate p-value for two-sided Fisher’s exact test comparing the fraction of anaphases with lagging chromosomes). (c) The fraction of cells in each cell line that undergo indicated fates after completing a mitosis deficient of KIF18A that resulted in micronuclei formation (n = 25 cells per condition). (d) The fraction of cells in each cell line that experience mitotic death in their first and second mitoses following KIF18A depletion (n = 25 cells per condition). (e) KIF18A essentiality scores for WGD – and WGD + cell lines segregated into “highly aneuploid” (AS > 10) and “non-highly aneuploid” categories based on aneuploidy score (AS) (see ) (dotted lines show mean; Wilcoxon rank-sum test – two-sided; p-values = 0.02583, 0.3682, respectively). (f) Aneuploidy scores and WGD status for 998 cancer cell lines in the CCLE. (g) Relative viability of indicated cell lines 7 days after transfection with the indicated siRNAs (n = 3 independent experiments; each condition normalized to respective control; one-way ANOVA with Dunnett’s post hoc test; graph shows mean +/− SEM; p-values = 0.1676, > 0.9999, 0.0040, 0.2698, 0.0007, respectively). * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001
Article Snippet: We infected cells with a
Techniques: Transfection, Control